reSee.it - Related Video Feed

Peter Attia discusses the significance of biological markers such as VO2 max, muscle mass, and strength in relation to longevity and quality of life, emphasizing that while nothing can be definitively proven in biology, the probability of these factors positively impacting lifespan is high. The podcast celebrates its 300th episode by categorizing various drugs, supplements, and interventions into "proven," "promising," "fuzzy," "noise," and "nonsense." Attia explains that "proven" refers to well-established data with a very low probability of being untrue, while "promising" indicates good data but missing pieces. "Fuzzy" suggests inconsistent or contradictory data, "noise" implies insufficient quality data, and "nonsense" denotes claims that have been thoroughly debunked. The discussion includes geroprotective drugs like rapamycin, which Attia categorizes as "promising" due to its effects observed in animal studies, but notes the lack of sufficient human data. Metformin is placed in the "fuzzy" category, with mixed evidence regarding its benefits for longevity. NAD and its precursors are considered "noise," as the current evidence does not convincingly support their geroprotective claims. Resveratrol is deemed "nonsense," with Attia citing a lack of credible evidence supporting its efficacy. Attia emphasizes the importance of exercise, stating that high VO2 max and muscle strength are among the strongest predictors of longevity, far outweighing the effects of various supplements. He discusses blood flow restriction training as "promising," particularly for rehabilitation, and expresses skepticism about stem cell therapies due to inconsistent data. In nutrition, Attia categorizes long-term fasting as "fuzzy," acknowledging its historical significance but highlighting the need for more robust data. He addresses the energy balance theory, placing it between "promising" and "proven," and critiques the oversimplification of sugar as "poison," advocating for a nuanced understanding of dietary patterns. Finally, he categorizes the claim that red meat causes cancer as "nonsense," arguing that the evidence does not support a direct causal relationship. The episode concludes with Attia expressing excitement for future discussions and the evolving nature of scientific understanding.

In this episode of the Huberman Lab podcast, Dr. Andrew Huberman interviews Dr. David Sinclair, a professor of genetics at Harvard Medical School, focusing on the biology of aging and interventions to slow or reverse aging. Sinclair views aging as a disease rather than a natural process, emphasizing that it can be addressed through various interventions, including behavioral changes, nutrition, and supplementation. Sinclair discusses the concept of "longevity" versus "anti-aging," explaining that while longevity refers to extending life, anti-aging has been misused in popular culture. He highlights the importance of understanding aging as a disease that contributes to many other health issues, such as heart disease and Alzheimer's. Sinclair's research identifies several "hallmarks" of aging, with a significant focus on the epigenome, which controls gene expression and influences cellular aging. The conversation delves into practical tools for combating aging, including dietary practices like intermittent fasting, which Sinclair advocates for its benefits in regulating insulin and glucose levels. He explains that elevated blood sugar and insulin can accelerate aging, while fasting can activate longevity genes, particularly sirtuins, which play a crucial role in cellular health. Sinclair shares his personal regimen, which includes skipping breakfast, taking supplements like NMN (Nicotinamide Mononucleotide) and resveratrol, and practicing intermittent fasting. He emphasizes the importance of measuring biological age through blood tests and other metrics to track health and optimize longevity strategies. The discussion also touches on the role of exercise, the impact of obesity on NAD levels, and the potential benefits of cold exposure. Sinclair mentions the significance of keeping inflammation low, particularly in the hypothalamus, which regulates aging and reproductive health. Sinclair's upcoming projects include a new podcast focused on aging and a biological age test that aims to democratize access to health metrics. He expresses optimism about the future of public education in science, highlighting the need for trusted sources of information in a world filled with misinformation. Overall, the episode provides insights into the mechanisms of aging, practical strategies for improving health, and the importance of scientific communication in promoting longevity.

Megyn Kelly opens the show reflecting on her Easter weekend and the importance of community and religious ceremonies. She introduces Dr. Peter Attia, whose new book "Outlive: The Science and Art of Longevity" is a bestseller and focuses on extending lifespan through health practices. Kelly discusses a recent shooting in Louisville, Kentucky, which is reported as workplace violence, resulting in five deaths, including the shooter. She criticizes the media's portrayal of the Tennessee lawmakers involved in a disruption during a legislative session following a school shooting, arguing that they were disrespectful and that their actions were misrepresented as heroic. She highlights Vice President Kamala Harris's visit to Nashville, noting her failure to meet with the victims' families. Glenn Greenwald joins the discussion, expressing frustration over the media's treatment of the Tennessee situation and the narrative surrounding it. He emphasizes that the shooter’s identity and motivations have been overlooked in favor of a racial narrative regarding the lawmakers' expulsion. Greenwald argues that the Democratic Party has shifted the focus from the victims to a race-based narrative, which he finds disingenuous. The conversation shifts to China hoarding food supplies, with Greenwald suggesting that this could indicate a looming global food crisis. He discusses the implications of this hoarding and the lack of transparency from the Chinese government. Kelly and Greenwald then address the political landscape, particularly the Democratic Party's tactics, including the use of race to frame political debates. They criticize the party's approach to dissent and the hypocrisy in their reactions to protests, comparing it to past incidents of political outrage. The discussion also touches on the implications of recent court rulings regarding abortion drugs and the Democrats' calls to ignore them, highlighting a perceived double standard in the party's approach to law and order. Returning to health, Dr. Attia discusses the importance of preventive measures in healthcare, emphasizing that many diseases can be mitigated with early intervention. He explains the significance of understanding one's genetic predispositions and the need for personalized health strategies. Attia outlines the "Four Horsemen of Death"—heart disease, cancer, neurodegenerative diseases, and metabolic disorders—stressing the importance of addressing these through lifestyle changes. He advocates for exercise as a critical factor in longevity and discusses the role of diet, emphasizing that there is no one-size-fits-all approach. The conversation concludes with Attia discussing the potential of medications like metformin and rapamycin in extending lifespan, while cautioning against relying solely on pharmaceuticals without addressing lifestyle factors. He encourages listeners to take an active role in their health by seeking out comprehensive testing and understanding their unique health profiles.

In this episode of the Peter Attia Drive, host Peter Attia interviews Professor David Sinclair, a prominent researcher in the field of aging and genetics at Harvard Medical School. Sinclair discusses his early interest in aging, which began when he was four years old, and his journey through academia, including his PhD in molecular genetics and his postdoctoral work at MIT under Lenny Guarente. Sinclair is known for his research on sirtuins, a class of proteins that play a crucial role in cellular regulation and aging. The conversation delves into the significance of sirtuins and their relationship with NAD (nicotinamide adenine dinucleotide), a vital molecule for cellular metabolism. Sinclair explains that sirtuins are involved in DNA repair and gene silencing, and their activity is dependent on NAD levels. He discusses the discovery of resveratrol, a compound that activates sirtuins and gained popularity due to its association with the health benefits of red wine. However, Sinclair clarifies that the claims surrounding resveratrol's effects on longevity are more complex than often portrayed. Attia and Sinclair explore the potential of NAD precursors like NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) in promoting health and longevity. Sinclair shares insights from ongoing research, including the challenges of delivering these compounds effectively and the need for clinical trials to assess their efficacy in humans. He emphasizes the importance of understanding the mechanisms behind aging and the potential for interventions that could extend healthspan. The discussion also touches on Sinclair's personal use of supplements like resveratrol and metformin, reflecting his commitment to experimenting with longevity-enhancing compounds. Sinclair expresses optimism about the future of aging research, highlighting advancements in technology and the growing interest in the field. Sinclair concludes by discussing the broader implications of aging research, including the potential societal impacts of extending human lifespan and the ethical considerations involved. He encourages listeners to remain informed and engaged with the evolving science of aging, emphasizing that while the journey is complex, the pursuit of understanding and improving healthspan is a worthy endeavor.

David Sinclair discusses his recent experiences with extreme workouts, including Laird Hamilton's sauna and ice bath regimen, emphasizing the mental and physical benefits of pushing one's limits. He explains the concept of hormesis, where mild stressors, such as temperature variations, can activate longevity genes and improve health. Sinclair highlights the importance of consuming stressed foods, which contain beneficial compounds that signal the body to prepare for adversity, thus promoting longevity. He elaborates on the role of sirtuins, enzymes that regulate cellular health, and their relationship with NAD, a molecule crucial for energy production and cellular repair. Sinclair notes that lifestyle choices, such as exercise, diet, and fasting, significantly influence aging, with approximately 80% of health outcomes attributed to lifestyle rather than genetics. He advocates for a predominantly plant-based diet, cautioning against excessive protein intake, which can inhibit the body's protective mechanisms. Sinclair shares insights on the Horvath clock, a biological measure of aging, and discusses the potential for reversing aging through innovative research, including gene therapy. He expresses optimism about the future of longevity science, envisioning a world where people can live healthier, longer lives, and where aging is treated as a manageable condition rather than an inevitable decline. He also addresses the ethical implications of extending lifespan, suggesting that healthier individuals tend to have fewer children, which could alleviate concerns about overpopulation. Sinclair emphasizes the need for a cultural shift towards valuing the wisdom of the elderly and integrating them into society, rather than marginalizing them. In terms of personal health practices, Sinclair shares his regimen, which includes intermittent fasting, regular exercise, and specific supplements like NMN and resveratrol, which he believes support longevity. He concludes by highlighting the importance of ongoing research and the potential for breakthroughs that could redefine aging and health in the future.

In this AMA episode of the Huberman Lab podcast, Andrew Huberman discusses the efficacy of resveratrol and other supplements for longevity. He states that while resveratrol may have health benefits, there is little evidence it extends lifespan. Huberman takes grape seed extract for vascular health but does not consider it a top supplement. He also explores NAD-related supplements like NR and NMN, which he takes for energy rather than lifespan extension. Huberman emphasizes that foundational health practices—quality sleep, exercise, nutrition, and social connections—are crucial for longevity, far outweighing any supplement benefits. He advises consulting a physician before making changes to supplement regimens.

In this episode of the Huberman Lab podcast, Andrew Huberman speaks with Dr. Peter Attia about the NAD pathway and its implications for healthspan and lifespan. Dr. Attia, a respected voice in longevity research, discusses various molecules related to NAD, including NR (Nicotinamide Riboside) and NMN (Nicotinamide Mononucleotide), and their potential effects on cellular health and aging. The conversation begins with an overview of four categories of approaches to longevity: essential behavioral practices (like exercise and nutrition), the role of caloric intake and insulin regulation (mTOR pathway), targeting specific cellular pathways (like NAD), and more esoteric methods. They emphasize the importance of foundational behaviors such as movement, sleep, and diet over supplements. Dr. Attia explains that NAD is crucial for energy production and is involved in over 600 cellular pathways. As people age, NAD levels decline, which may affect DNA repair and mitochondrial function. They discuss the potential benefits of NAD supplementation, but both express skepticism about its efficacy for extending lifespan. They highlight that while NAD levels can be increased through supplements, there is no strong evidence that this translates to significant health or longevity benefits. The discussion also touches on the Interventions Testing Program (ITP), which has tested numerous compounds for lifespan extension, with few showing positive results. Notably, rapamycin has demonstrated consistent life-extending effects in various studies, unlike NAD precursors. Dr. Attia shares his personal supplement regimen, which includes rapamycin, fish oil, vitamin D, and others, while emphasizing that lifestyle choices are more impactful than supplements. He notes that while he occasionally takes NAD precursors, he does not believe they significantly contribute to longevity. The episode concludes with a reminder that while supplements can play a role in health, they should not replace essential lifestyle practices. Both hosts agree that exercise, nutrition, and emotional well-being are the primary drivers of healthspan and lifespan, and they encourage listeners to focus on these foundational elements rather than solely on supplementation.

Joe Rogan welcomes David Sinclair, author of "Lifespan," to discuss aging and potential ways to combat it. Sinclair shares insights on metformin, DHEA, and human growth hormone, referencing a recent study suggesting these could biologically reduce age by two years. He explains that biological age is measured using the Horvath clock, which assesses chemical modifications in DNA rather than traditional metrics like telomere length. Sinclair emphasizes the potential for reversing aging, not just slowing it down, and discusses the implications of the Horvath clock in understanding aging. He mentions antioxidants, particularly resveratrol, which he still takes, and explains its role in stimulating the body’s defenses against aging rather than acting solely as an antioxidant. The conversation shifts to the effects of metformin on physical performance, with Sinclair suggesting a pulsing approach—taking it on non-exercise days—to mitigate any performance hits. They discuss the need for more research on combinations of anti-aging treatments, including NMN and rapamycin. Sinclair describes his recent trip to Africa, where he observed wildlife and reflected on human origins. He shares experiences of seeing the natural world and discusses the importance of supporting indigenous communities, like the Batwa tribe, who face challenges due to conservation efforts. The discussion returns to aging, with Sinclair highlighting the role of senolytics—drugs that target and eliminate senescent cells—as a promising avenue for rejuvenation. He explains that these cells contribute to aging by causing inflammation and other issues. Sinclair also discusses CRISPR technology, which allows for precise genetic modifications, and its potential applications in reversing aging and treating diseases. He expresses optimism about the future of medicine, including the possibility of rejuvenating vision and repairing spinal injuries. Throughout the conversation, Sinclair emphasizes the importance of lifestyle choices, such as diet, exercise, and stress management, in promoting longevity. He encourages listeners to consider the implications of emerging research and technologies on their health and lifespan, suggesting that we may be on the brink of significant breakthroughs in understanding and combating aging.

Andrew Huberman and Dr. David Sinclair discuss aging, defining it as a disease rather than an inevitable process, arguing that it's the primary cause of most chronic illnesses. Sinclair posits that aging is fundamentally a loss of information within cells, akin to "scratches on a CD," primarily affecting the epigenome—the system controlling gene expression. These "scratches" are caused by factors like DNA damage (e.g., X-rays, sun exposure) and cellular stress, leading to cells losing their identity and function. Interestingly, periods of rapid development, like early life, show accelerated biological aging according to epigenetic clocks. Sinclair emphasizes that while genetics play a role, 80% of longevity is influenced by epigenetic information, which can be positively modified by lifestyle. A key actionable protocol is intermittent fasting, which activates longevity genes called sirtuins by keeping insulin and insulin-like growth factor levels low. This contrasts with constant feeding, which keeps these protective genes inactive. Skipping a meal daily is recommended, with longer fasts (2-3 days) triggering deeper cellular cleansing processes like chaperone-mediated autophagy, which has shown significant lifespan extension in mice. The conversation also covers supplementation, with Sinclair discussing his personal use of NMN to boost NAD levels, which are crucial for sirtuin activity. He highlights the importance of personalized medicine and tracking biomarkers like HbA1c (average glucose) and C-reactive protein (CRP) for inflammation, a strong predictor of cardiovascular disease and mortality. Exercise, particularly for maintaining muscle mass and hormone levels, is also crucial. Sinclair shares groundbreaking research on rejuvenating the female reproductive system in old mice using NMN, challenging conventional biological understanding and suggesting the body's remarkable capacity for repair and rejuvenation.

Chris Williamson interviews Professor David Sinclair at Harvard Medical School, discussing aging and longevity research. Sinclair leads a lab focused on understanding aging and developing methods to slow or reverse it. He explains that his lab's work involves activating the body's defenses against aging, eliminating harmful senescent cells, and using partial cellular reprogramming to rejuvenate cells. Sinclair shares that he is biologically older than his chronological age due to slightly elevated glucose levels. He emphasizes the importance of calorie restriction and intermittent fasting, which have been shown to extend lifespan across various species. Sinclair takes metformin, an anti-diabetic drug, and NAD boosters to support his longevity efforts. The conversation touches on the potential for genetic engineering to enhance human lifespan, including the ethical implications of CRISPR technology. Sinclair believes that aging can be treated as a disease, and he envisions a future where people can rejuvenate their cells and potentially live much longer lives. Sinclair also discusses the societal implications of increased longevity, including the economic benefits of healthier, longer-living populations. He argues that advancements in longevity science could lead to significant savings in healthcare costs and improve overall productivity. Finally, Sinclair mentions his upcoming book, "Lifespan: The Revolutionary Science of Why We Age and Why We Don't Have To," which aims to provide insights into aging and longevity. He encourages listeners to engage with the science of aging and consider their health strategies early in life.

In a discussion about popular supplements, Brad Stanfield critiques Resveratrol, highlighting that its initial hype in longevity research is largely unfounded. He explains that while Resveratrol was thought to activate the sirtuin one gene for lifespan extension, subsequent studies failed to replicate these findings, revealing that its effects in mice were due to a toxic diet rather than genuine benefits. Moreover, human studies indicate that Resveratrol may lower testosterone levels and diminish exercise benefits, leading Stanfield to advise against its use. He also addresses NMN and NR, which gained popularity after being discussed by David Sinclair on The Joe Rogan podcast. Despite initial excitement, randomized trials have shown no significant health improvements from these supplements in humans. Stanfield emphasizes the importance of lifestyle changes over supplements, noting that exercise and diet are paramount for health. Regarding metformin, Stanfield acknowledges its initial promise based on mouse studies and observational human studies but cites recent research showing no lifespan extension in non-diabetics and potential risks, such as blunting exercise benefits. He advocates for lifestyle modifications as the most effective means of preventing chronic diseases. The conversation shifts to effective supplements like creatine, collagen peptides, and hyaluronic acid, which have strong evidence supporting their benefits, particularly for muscle recovery and skin health. Stanfield stresses the importance of a balanced diet rich in protein, fiber, and healthy fats while cautioning against excessive saturated fat intake. Ultimately, he encourages individuals to prioritize exercise, a healthy diet, and informed supplement choices, while remaining skeptical of the hype surrounding many popular supplements.

David Sinclair discusses the potential of anti-aging research, emphasizing that stopping or reversing aging is a realistic goal based on laboratory findings. He shares his personal regimen, which includes intermittent fasting, exercise, and supplements like NMN and resveratrol, which are linked to longevity through their effects on sirtuin genes. Sinclair explains that these genes protect against deterioration and disease, and their activation can be mimicked with certain molecules. He highlights the importance of timing in eating for longevity, noting that intermittent fasting has shown significant benefits in animal studies. Sinclair believes that combining healthy lifestyle choices with these molecules can enhance their effects, leading to improved health outcomes. Sinclair also addresses the role of metformin, a diabetes medication he takes for its potential anti-aging benefits, and discusses the mechanisms behind it, including its activation of AMPK, a pathway related to longevity. He mentions the significance of NAD levels, which decline with age, and how NMN and other supplements can help restore these levels. The conversation shifts to the challenges of scientific research, including the competitive nature of the field and the skepticism faced by those proposing new theories. Sinclair recounts his experiences of being criticized early in his career but ultimately being validated by subsequent research findings. He discusses the ethical considerations in genetic research, particularly with CRISPR technology, and the potential for gene editing to prevent diseases. Sinclair expresses his belief that aging should be classified as a disease to encourage more research and funding in the field. Sinclair also touches on the societal implications of extending human lifespan, including the potential impact on population growth and healthcare systems. He believes that addressing aging could alleviate pressures on healthcare and improve overall quality of life. He concludes by emphasizing the importance of collaboration in scientific research and the need for transparency in the pharmaceutical industry. Sinclair is optimistic about the future of anti-aging research and the potential for breakthroughs that could significantly extend healthy human lifespan.

David Sinclair discusses the concept of aging, emphasizing that there is no biological law mandating aging and that many centenarians often neglect their health. He expresses a desire to alleviate the suffering caused by aging, noting that over 100,000 people die daily from age-related issues. Sinclair highlights the economic burden of aging, estimating that slowing down aging by just one year could save the U.S. $86 trillion over three decades, which could be redirected towards education and healthcare. Aging, he explains, is linked to the loss of epigenetic information that regulates gene expression. This disruption leads to diseases and dysfunctions, which are often treated only at their end stages rather than addressing the root cause—aging itself. Sinclair uses the analogy of a scratched DVD to describe how aging affects our genetic information, suggesting that recent research indicates potential methods to "polish" these scratches. Sinclair advocates for lifestyle changes to reduce biological age, such as fasting, which activates epigenetic regulators known as sirtuins. He explains that adversity, including fasting and dietary choices, can stimulate these genes, promoting longevity. He recommends a Mediterranean diet rich in plants, which has been shown to activate longevity pathways. He also discusses the importance of exercise, emphasizing that even minimal aerobic activity can yield significant health benefits. Sinclair notes that psychological stress negatively impacts longevity, while a positive outlook and sense of purpose can contribute to a longer life. On supplements, Sinclair takes NMN, resveratrol, and Athletic Greens to support his health. He believes that while supplements can aid longevity, they should complement a healthy lifestyle rather than replace it. He mentions ongoing research into cellular reprogramming and potential breakthroughs that could extend human lifespan significantly. Sinclair concludes that while there may be limits to human lifespan, advancements in science and lifestyle choices can potentially allow individuals to live much longer, healthier lives. He encourages proactive health management and emphasizes the importance of making informed lifestyle choices to enhance longevity.

In this episode of the Huberman Lab podcast, Andrew Huberman and Dr. Peter Attia conduct their first Journal Club, discussing two significant research papers. Dr. Attia focuses on a paper regarding Metformin, a drug commonly used for type 2 diabetes, and its potential longevity benefits. He explains that Metformin works by inhibiting mitochondrial complex one, which reduces hepatic glucose output, a key issue in type 2 diabetes. The discussion highlights a 2014 study by Bannister that suggested Metformin could provide a survival advantage for diabetics, showing a 15% reduction in all-cause mortality. However, Dr. Attia critiques this study for its methodological limitations, particularly its use of informative censoring, which excluded patients who deviated from the study criteria. Dr. Attia then introduces a new paper by Keys et al., which reassesses the findings of the Bannister study using a larger cohort from a Danish health registry. This study compares diabetics on Metformin with matched controls and discordant twins. The results indicate that diabetics on Metformin had a higher mortality rate compared to non-diabetics, with hazard ratios suggesting a 48% increased risk of death. The findings challenge the notion that Metformin provides significant protective benefits against mortality in type 2 diabetics. Huberman then presents a paper on the placebo effect, emphasizing that beliefs about treatment can influence physiological responses. The study demonstrates that the placebo effect can follow a dose-response relationship, meaning that the perceived strength of a treatment can enhance its effectiveness. This was illustrated through an experiment where participants vaped nicotine and reported their experiences based on the dosage they believed they received. The brain's response, measured through fMRI, showed that those who believed they received a higher dose exhibited greater activation in brain areas associated with attention and reward. The conversation explores the implications of these findings for understanding how beliefs can shape health outcomes, particularly in the context of medications and treatments. Dr. Attia and Huberman emphasize the importance of critically evaluating scientific literature and understanding the nuances of research methodologies. They conclude that while Metformin remains a valuable treatment for type 2 diabetes, its role in longevity is still uncertain, and the belief effects discussed could have broad applications in medicine and health practices.

Peter Attia welcomes Matt Kaeberlein back to The Drive podcast, where they discuss aging, the mTOR pathway, and interventions like rapamycin. They explore the definitions of aging, with Kaeberlein emphasizing the importance of both molecular and functional perspectives. He notes that aging can be defined by cellular damage, such as mitochondrial dysfunction and telomere shortening, but also by functional declines like frailty. The conversation shifts to the relationship between aging and disease. Kaeberlein argues that functional declines often precede clinical diagnoses of diseases like cardiovascular disease and dementia. He believes that while biological aging contributes to disease risk, it is not the sole cause, and interventions targeting biological aging may not be effective once a disease has progressed significantly. They discuss rapamycin, a drug that inhibits the mTOR pathway, which has shown promise in extending lifespan in animal models. Kaeberlein highlights that while rapamycin can prevent certain diseases, its effectiveness may diminish once a disease has developed due to changes in cellular mechanisms. They also touch on the challenges of studying aging in humans and the regulatory hurdles that complicate clinical trials for aging interventions. Kaeberlein shares insights from his work on aging in dogs, particularly through the Dog Aging Project, which aims to understand aging and test interventions like rapamycin in companion dogs. He explains that dogs provide a unique model for studying aging due to their genetic diversity and shared environment with humans. The ongoing TRIAD study aims to assess the effects of rapamycin on lifespan and healthspan in dogs. The discussion then transitions to NAD precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), which are thought to boost sirtuin activity and potentially improve health outcomes. Kaeberlein expresses skepticism about the robustness of the data supporting these compounds, noting that while they may have some benefits, they do not compare to the effects of rapamycin. Finally, they discuss the complexities of measuring biological aging and the need for reliable biomarkers. Kaeberlein emphasizes the importance of understanding the mechanisms of aging to develop effective interventions. The conversation concludes with Attia expressing gratitude for Kaeberlein's insights and wishing him success with the TRIAD study.

David Sinclair emphasizes the importance of maintaining NAD levels for longevity, suggesting that caloric restriction and exercise are key to activating the body's survival circuits. He argues that aging should be viewed as a disease that can be treated, rather than an inevitable process. Sinclair's interest in aging began in childhood, influenced by his grandmother's perspective on life and mortality. He believes that understanding and potentially reversing aging could lead to healthier, longer lives. Sinclair discusses the role of sirtuins, enzymes that require NAD to function, in repairing DNA and regulating gene expression. He highlights the significance of epigenetics, suggesting that aging is more about the loss of epigenetic information than genetic mutations. Sinclair's research indicates that lifestyle factors, such as diet and exercise, can enhance NAD levels and activate sirtuins, promoting cellular repair and longevity. He introduces NMN (nicotinamide mononucleotide) as a supplement that can boost NAD levels, potentially reversing aspects of aging. Sinclair is conducting clinical trials to test the efficacy of NMN in humans, aiming for FDA approval. He believes that if successful, these treatments could significantly extend healthspan and lifespan. Sinclair also addresses the societal implications of increased longevity, including the potential for overpopulation and the need for a shift in how we view aging and the elderly. He advocates for a future where older individuals remain productive and engaged in society, leveraging their wisdom and experience. He concludes by emphasizing the importance of purpose and community in longevity, suggesting that maintaining a sense of mission in life is crucial for overall well-being. Sinclair encourages listeners to adopt healthy habits, including regular exercise, a balanced diet, and mindfulness practices, to enhance their longevity and quality of life.

In this episode of The Drive, host Peter Attia welcomes back Professor David Sinclair, a prominent researcher in the field of aging and longevity. Sinclair is known for his work on sirtuins and the role of NAD (nicotinamide adenine dinucleotide) in aging. The discussion centers around Sinclair's new book, which explores the information theory of aging, the biological mechanisms behind aging, and potential interventions to extend lifespan. Attia explains his decision to rely on listener support for the podcast instead of advertisements, emphasizing the importance of trust and the desire to provide unbiased information. Sinclair shares insights into his research, particularly the significance of sirtuins, which are proteins that regulate cellular health and longevity. He discusses the discovery of sirtuins in yeast and their connection to dietary restriction and aging. The conversation delves into the concept of the information theory of aging, which posits that aging is a loss of information in the body's cells. Sinclair explains how this theory relates to the maintenance of cellular identity and the role of epigenetic modifications, such as DNA methylation, in aging. He likens the aging process to a loss of cellular identity, where cells revert to a more primitive state. Sinclair introduces the idea of reprogramming cells to restore youthful characteristics, drawing parallels to stem cell technology. He discusses ongoing research that suggests it may be possible to reset the aging clock in cells, potentially leading to significant health improvements. The conversation also touches on the implications of extending human lifespan, including ethical considerations and societal impacts. The discussion shifts to NAD and its precursors, such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Sinclair explains how these compounds can boost NAD levels in the body, which is crucial for sirtuin activity and overall cellular function. He highlights the differences between oral and intravenous administration of NAD and the challenges associated with absorption and bioavailability. Attia and Sinclair explore the potential benefits of NAD supplementation, particularly for individuals with metabolic disorders or age-related decline. Sinclair emphasizes the importance of ongoing research to determine the efficacy of NAD boosters in humans and the need for well-designed clinical trials. The episode concludes with Sinclair discussing his artistic endeavors, including the illustrations in his book, and Attia expressing his appreciation for Sinclair's insights and contributions to the field of longevity research. Sinclair's book aims to provide a fresh perspective on aging and the potential for extending healthy lifespan through scientific advancements.